Back to Search Start Over

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.

Authors :
Smits, Lisa J T
Esch, Aura A J van
Derikx, Lauranne A A P
Boshuizen, Ronald
Jong, Dirk J de
Drenth, Joost P H
Hoentjen, Frank
Source :
Inflammatory Bowel Diseases; Jan2019, Vol. 25 Issue 1, p172-179, 8p
Publication Year :
2019

Details

Language :
English
ISSN :
10780998
Volume :
25
Issue :
1
Database :
Complementary Index
Journal :
Inflammatory Bowel Diseases
Publication Type :
Academic Journal
Accession number :
135979692
Full Text :
https://doi.org/10.1093/ibd/izy227